| 1 | Ovarian cancer | Enrichment | AKT1, ATM, BLM, BMPR1A, BRCA1, BRCA2, FANCA, FANCG, KIT, NBN, PTEN, RECQL4, TSC2, WRN, WT1 | 16.00 |
| 2 | Breast cancer | Enrichment | AKT1, ATM, BLM, BRCA1, BRCA2, CYP17A1, ESR1, FANCM, IL2, NBN, PTEN, RAD51, XRCC2 | 10.95 |
| 3 | 46 xx gonadal dysgenesis | Enrichment | BMP15, BNC1, FIGLA, FSHR, MRPS22, MSH4, NR5A1, NUP107, POLR3H, PSMC3IP, SPIDR | 10.91 |
| 4 | Primary ovarian insufficiency | Enrichment | AFF2, BNC1, CYP17A1, CYP19A1, EIF2B2, FANCA, GALT, KDR, KHDRBS1, MND1, MSH4, NBN, NOBOX, NOTCH2, POLG, PREPL, PRLR, STAG3, TP63, WT1 | 10.53 |
| 5 | Hereditary breast carcinoma | Enrichment | AKT1, ATM, BLM, BRCA1, BRCA2, ESR1, FANCM, NBN, PTEN, RAD51 | 9.80 |
| 6 | Perrault syndrome 2 | Enrichment | CLPP, ERAL1, HARS2, HSD17B4, LARS2, TWNK | 9.47 |
| 7 | Perrault syndrome 1 | Enrichment | CLPP, ERAL1, FSHR, HARS2, HSD17B4, LARS2, TWNK | 9.28 |
| 8 | Inherited cancer-predisposing syndrome | Enrichment | ATM, BLM, BMPR1A, BRCA1, BRCA2, FANCA, FANCM, KIT, NBN, PTEN, RECQL4, TSC2, WT1, XRCC2 | 8.88 |
| 9 | Hereditary breast ovarian cancer syndrome | Enrichment | ATM, BLM, BRCA1, BRCA2, EIF2B5, FANCM, NBN, PTEN, RAD51, XRCC2 | 8.81 |
| 10 | Male infertility with azoospermia or oligozoospermia due to single gene mutation | Enrichment | BNC1, C14orf39, FANCM, GATA4, MEIOB, MSH5, NR5A1, STAG3, SYCE1, XRCC2 | 8.72 |
| 11 | Azoospermia | Enrichment | C14orf39, DMC1, FANCM, HFM1, MCM8, MEIOB, MSH5 | 8.48 |
| 12 | Premature menopause | Enrichment | EIF2B2, MSH4, NBN, PREPL, STAG3, TP63 | 8.20 |
| 13 | Fanconi anemia, complementation group a | Enrichment | BRCA1, BRCA2, FANCA, FANCG, FANCL, FANCM, RAD51, XRCC2 | 7.98 |
| 14 | Leukoencephalopathy with vanishing white matter | Enrichment | AARS2, EIF2B2, EIF2B3, EIF2B4, EIF2B5 | 7.41 |
| 15 | Leukoencephalopathy with vanishing white matter 1 | Enrichment | EIF2B2, EIF2B3, EIF2B4, EIF2B5 | 6.06 |
| 16 | Leukoencephalopathy with vanishing white matter 5 | Enrichment | EIF2B2, EIF2B3, EIF2B4, EIF2B5 | 5.76 |
| 17 | Endometrial cancer | Enrichment | ATM, BLM, BRCA1, BRCA2, PTEN | 5.26 |
| 18 | Uterine corpus cancer | Enrichment | ATM, BRCA1, BRCA2, PTEN | 5.10 |
| 19 | Pancreatic cancer | Enrichment | ATM, BRCA1, BRCA2, FANCG, NBN | 4.86 |
| 20 | Breast-ovarian cancer, familial 1 | Enrichment | ATM, BRCA1, BRCA2, NBN | 4.78 |
| 21 | Prostate cancer | Enrichment | ATM, BRCA1, BRCA2, NBN, PTEN | 4.53 |
| 22 | Diffuse large b-cell lymphoma | Enrichment | BRCA2, FOXO1, NBN, PTEN | 4.07 |
| 23 | Perrault syndrome | Enrichment | HARS2, HSD17B4, LARS2 | 3.96 |
| 24 | Short stature, microcephaly, and endocrine dysfunction | Enrichment | XRCC2, XRCC4 | 3.79 |
| 25 | 46,xy sex reversal 3 | Enrichment | GATA4, NR5A1 | 3.79 |
| 26 | Inflammatory breast carcinoma | Enrichment | BRCA1, BRCA2 | 3.79 |
| 27 | Bilateral breast cancer | Enrichment | BRCA1, BRCA2 | 3.79 |
| 28 | Juvenile polyposis of infancy | Enrichment | BMPR1A, PTEN | 3.79 |
| 29 | Gastric cancer | Enrichment | ATM, BRCA1, BRCA2, NBN, PTEN | 3.68 |
| 30 | 46,xy complete gonadal dysgenesis | Enrichment | CBX2, NR5A1, WT1 | 3.51 |
| 31 | Familial colorectal cancer type x | Enrichment | ATM, BMPR1A, BRCA2 | 3.51 |
| 32 | Bladder cancer | Enrichment | ATM, BRCA1, BRCA2, PTEN | 3.33 |
| 33 | Migraine without aura | Enrichment | ESR1, TNF | 3.32 |
| 34 | 46,xy partial gonadal dysgenesis | Enrichment | GATA4, NR5A1, WT1 | 3.17 |
| 35 | Polyposis syndrome, hereditary mixed, 1 | Enrichment | BRCA1, BRCA2 | 3.02 |
| 36 | Persistent mullerian duct syndrome, types i and ii | Enrichment | AMH, AMHR2 | 3.02 |
| 37 | Propionic acidemia | Enrichment | PCCA, PCCB | 3.02 |
| 38 | Cholangiocarcinoma | Enrichment | BRCA1, BRCA2 | 3.02 |
| 39 | Persistent mullerian duct syndrome | Enrichment | AMH, AMHR2 | 3.02 |
| 40 | Systemic-onset juvenile idiopathic arthritis | Enrichment | HLA-DRB1, IL6 | 3.02 |
| 41 | Rhabdomyosarcoma | Enrichment | BRCA1, BRCA2, PTEN | 3.00 |
| 42 | Premature ovarian failure 1 | Enrichment | FMR1, MCM9 | 2.80 |
| 43 | Sensory ataxic neuropathy, dysarthria, and ophthalmoparesis | Enrichment | POLG, TWNK | 2.80 |
| 44 | Breast-ovarian cancer, familial 2 | Enrichment | BRCA1, BRCA2 | 2.80 |
| 45 | Diffuse cutaneous systemic sclerosis | Enrichment | CAV1, HLA-DRB1 | 2.80 |
| 46 | Hepatoblastoma | Enrichment | BRCA2, FANCA, RECQL4 | 2.64 |
| 47 | Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1 | Enrichment | POLG, TWNK | 2.63 |
| 48 | Wilms tumor, aniridia, genitourinary anomalies, and impaired intellectual development syndrome | Enrichment | BDNF, WT1 | 2.63 |
| 49 | Hemangioma, capillary infantile | Enrichment | ANTXR1, KDR | 2.63 |
| 50 | Limited scleroderma | Enrichment | CAV1, HLA-DRB1 | 2.63 |
| 51 | Congenital nervous system abnormality | Enrichment | EIF2B2, HSD17B4, POLG, PTEN, TSC2, WDR62 | 2.63 |
| 52 | Nervous system disease | Enrichment | EIF2B2, HSD17B4, POLG, PTEN, TSC2, WDR62 | 2.63 |
| 53 | Body mass index quantitative trait locus 11 | Enrichment | BDNF, GNAS, PCSK1, POLG | 2.43 |
| 54 | Isolated growth hormone deficiency, type ia | Enrichment | BRCA2, XRCC4 | 2.37 |
| 55 | Difference of sex development | Enrichment | NR5A1, WT1 | 2.37 |
| 56 | Colorectal cancer | Enrichment | AKT1, ATM, BLM, BRCA1, BRCA2 | 2.30 |
| 57 | Cowden syndrome | Enrichment | AKT1, PTEN | 2.26 |
| 58 | Heritable pulmonary arterial hypertension | Enrichment | BMPR2, CAV1 | 2.08 |
| 59 | Meningioma | Enrichment | AKT1, PTEN | 2.01 |
| 60 | Blepharophimosis, ptosis, and epicanthus inversus | Enrichment | FOXL2 | 1.89 |
| 61 | Palmoplantar keratoderma, punctate type ii | Enrichment | BRCA1 | 1.89 |
| 62 | Rapp-hodgkin syndrome | Enrichment | TP63 | 1.89 |
| 63 | Ankyloblepharon-ectodermal defects-cleft lip/palate | Enrichment | TP63 | 1.89 |
| 64 | Proteus syndrome | Enrichment | AKT1 | 1.89 |
| 65 | Mullerian aplasia and hyperandrogenism | Enrichment | WNT4 | 1.89 |
| 66 | Bloom syndrome | Enrichment | BLM | 1.89 |
| 67 | Gapo syndrome | Enrichment | ANTXR1 | 1.89 |
| 68 | Stapes ankylosis with broad thumbs and toes | Enrichment | NOG | 1.89 |
| 69 | Tarsal-carpal coalition syndrome | Enrichment | NOG | 1.89 |
| 70 | Bamforth-lazarus syndrome | Enrichment | FOXE1 | 1.89 |
| 71 | Vacterl association with hydrocephalus | Enrichment | PTEN | 1.89 |
| 72 | Intellectual developmental disorder, x-linked, syndromic 35 | Enrichment | RPL10 | 1.89 |
| 73 | Rapadilino syndrome | Enrichment | RECQL4 | 1.89 |
| 74 | Split-hand/foot malformation 4 | Enrichment | TP63 | 1.89 |
| 75 | 46,xy sex reversal 5 | Enrichment | CBX2 | 1.89 |
| 76 | Ankyloblepharon filiforme adnatum and cleft palate | Enrichment | TP63 | 1.89 |
| 77 | Pseudohypoparathyroidism, type ic | Enrichment | GNAS | 1.89 |
| 78 | Lipodystrophy, congenital generalized, type 3 | Enrichment | CAV1 | 1.89 |
| 79 | 46,xx sex reversal with dysgenesis of kidneys, adrenals, and lungs | Enrichment | WNT4 | 1.89 |
| 80 | Mastocytosis, cutaneous | Enrichment | KIT | 1.89 |
| 81 | Polyposis syndrome, hereditary mixed, 2 | Enrichment | BMPR1A | 1.89 |
| 82 | Acromesomelic dysplasia 3 | Enrichment | BMPR1B | 1.89 |
| 83 | Brachydactyly, type b2 | Enrichment | NOG | 1.89 |
| 84 | Osseous heteroplasia, progressive | Enrichment | GNAS | 1.89 |
| 85 | Premature ovarian failure 5 | Enrichment | NOBOX | 1.89 |
| 86 | Reticular dystrophy of retinal pigment epithelium | Enrichment | RCBTB1 | 1.89 |
| 87 | Hajdu-cheney syndrome | Enrichment | NOTCH2 | 1.89 |
| 88 | Alagille syndrome 2 | Enrichment | NOTCH2 | 1.89 |
| 89 | Autism 15 | Enrichment | CNTNAP2 | 1.89 |
| 90 | Spermatogenic failure 2 | Enrichment | MSH4 | 1.89 |
| 91 | Glioma susceptibility 3 | Enrichment | BRCA2 | 1.89 |
| 92 | Ivic syndrome | Enrichment | SALL4 | 1.89 |
| 93 | Adult syndrome | Enrichment | TP63 | 1.89 |
| 94 | Microcephaly 2, primary, autosomal recessive, with or without cortical malformations | Enrichment | WDR62 | 1.89 |
| 95 | Marinesco-sjogren syndrome | Enrichment | SIL1 | 1.89 |
| 96 | Mirror movements 2 | Enrichment | RAD51 | 1.89 |
| 97 | Multiple fibroadenomas of the breast | Enrichment | PRLR | 1.89 |
| 98 | Symphalangism, proximal, 1a | Enrichment | NOG | 1.89 |
| 99 | Multiple synostoses syndrome 1 | Enrichment | NOG | 1.89 |
| 100 | 46,xx sex reversal 4 | Enrichment | NR5A1 | 1.89 |
| 101 | Brachydactyly, type a1, d | Enrichment | BMPR1B | 1.89 |
| 102 | Spermatogenic failure 8 | Enrichment | NR5A1 | 1.89 |
| 103 | Ovarian dysgenesis 1 | Enrichment | FSHR | 1.89 |
| 104 | Pulmonary hypertension, primary, 3 | Enrichment | CAV1 | 1.89 |
| 105 | Atrioventricular septal defect 4 | Enrichment | GATA4 | 1.89 |
| 106 | Fanconi anemia, complementation group g | Enrichment | FANCG | 1.89 |
| 107 | Acth-independent macronodular adrenal hyperplasia 1 | Enrichment | GNAS | 1.89 |
| 108 | Premature ovarian failure 18 | Enrichment | C14orf39 | 1.89 |
| 109 | Retinal dystrophy with or without extraocular anomalies | Enrichment | RCBTB1 | 1.89 |
| 110 | Fanconi anemia, complementation group r | Enrichment | RAD51 | 1.89 |
| 111 | Fanconi anemia, complementation group u | Enrichment | XRCC2 | 1.89 |
| 112 | Twinning, dizygotic | Enrichment | FSHR | 1.89 |
| 113 | Leukoencephalopathy with vanishing white matter 3 | Enrichment | EIF2B3 | 1.89 |
| 114 | Autism x-linked 5 | Enrichment | RPL10 | 1.89 |
| 115 | Spermatogenic failure 28 | Enrichment | FANCM | 1.89 |
| 116 | Pituitary adenoma 3, multiple types | Enrichment | GNAS | 1.89 |
| 117 | Ovarian dysgenesis 5 | Enrichment | SOHLH1 | 1.89 |
| 118 | Premature ovarian failure 15 | Enrichment | FANCM | 1.89 |
| 119 | Ovarian dysgenesis 2 | Enrichment | BMP15 | 1.89 |
| 120 | Premature ovarian failure 17 | Enrichment | XRCC2 | 1.89 |
| 121 | Thyroid dyshormonogenesis 3 | Enrichment | TG | 1.89 |
| 122 | Hypothyroidism, congenital, nongoitrous, 4 | Enrichment | TSHB | 1.89 |
| 123 | Premature ovarian failure 2a | Enrichment | DIAPH2 | 1.89 |
| 124 | Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 3 | Enrichment | TWNK | 1.89 |
| 125 | Spermatogenic failure 50 | Enrichment | XRCC2 | 1.89 |
| 126 | Infant-type hemispheric glioma | Enrichment | BRCA1 | 1.89 |
| 127 | Hyperprolactinemia | Enrichment | PRLR | 1.89 |
| 128 | Plasminogen activator inhibitor-1 deficiency | Enrichment | SERPINE1 | 1.89 |
| 129 | Pancreatic cancer 2 | Enrichment | BRCA2 | 1.89 |
| 130 | Spermatogenic failure 15 | Enrichment | SYCE1 | 1.89 |
| 131 | Ovarian dysgenesis 4 | Enrichment | MCM9 | 1.89 |
| 132 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 3 | Enrichment | TP63 | 1.89 |
| 133 | Premature ovarian failure 20 | Enrichment | MSH4 | 1.89 |
| 134 | Papillary tumor of the pineal region | Enrichment | PTEN | 1.89 |
| 135 | Lipodystrophy, familial partial, type 7 | Enrichment | CAV1 | 1.89 |
| 136 | Premature ovarian failure 19 | Enrichment | HSF2BP | 1.89 |
| 137 | Neutropenia, severe congenital, 3, autosomal recessive | Enrichment | HAX1 | 1.89 |
| 138 | Premature ovarian failure 8 | Enrichment | STAG3 | 1.89 |
| 139 | Limb-mammary syndrome | Enrichment | TP63 | 1.89 |
| 140 | Pulmonary alveolar proteinosis, acquired | Enrichment | HLA-DRB1 | 1.89 |
| 141 | Perrault syndrome 5 | Enrichment | TWNK | 1.89 |
| 142 | Premature ovarian failure 6 | Enrichment | FIGLA | 1.89 |
| 143 | Ovarian dysgenesis 8 | Enrichment | ESR2 | 1.89 |
| 144 | Ovarian hyperstimulation syndrome | Enrichment | FSHR | 1.89 |
| 145 | Galloway-mowat syndrome 7 | Enrichment | NUP107 | 1.89 |
| 146 | Meacham syndrome | Enrichment | WT1 | 1.89 |
| 147 | Atrial septal defect 2 | Enrichment | GATA4 | 1.89 |
| 148 | Colorectal cancer, hereditary nonpolyposis, type 6 | Enrichment | TGFBR2 | 1.89 |
| 149 | Premature ovarian failure 10 | Enrichment | MCM8 | 1.89 |
| 150 | Premature ovarian failure 21 | Enrichment | TP63 | 1.89 |
| 151 | Cowden syndrome 6 | Enrichment | AKT1 | 1.89 |
| 152 | Combined oxidative phosphorylation deficiency 8 | Enrichment | AARS2 | 1.89 |
| 153 | Testicular anomalies with or without congenital heart disease | Enrichment | GATA4 | 1.89 |
| 154 | Amenorrhea | Enrichment | FSHR | 1.89 |
| 155 | Spermatogenic failure 52 | Enrichment | C14orf39 | 1.89 |
| 156 | Premature ovarian failure 7 | Enrichment | NR5A1 | 1.89 |
| 157 | Combined oxidative phosphorylation deficiency 5 | Enrichment | MRPS22 | 1.89 |
| 158 | Ovarian dysgenesis 9 | Enrichment | SPIDR | 1.89 |
| 159 | Endometrial serous adenocarcinoma | Enrichment | ATM | 1.89 |
| 160 | Premature ovarian failure 25 | Enrichment | SPATA22 | 1.89 |
| 161 | Disorders of gnas inactivation | Enrichment | GNAS | 1.89 |
| 162 | Glioma susceptibility 2 | Enrichment | PTEN | 1.89 |
| 163 | Nephrotic syndrome, type 11 | Enrichment | NUP107 | 1.89 |
| 164 | Premature ovarian failure 12 | Enrichment | SYCE1 | 1.89 |
| 165 | Hemangioma of liver | Enrichment | GJA4 | 1.89 |
| 166 | Fanconi anemia, complementation group l | Enrichment | FANCL | 1.89 |
| 167 | Orofacial cleft 8 | Enrichment | TP63 | 1.89 |
| 168 | Atypical werner syndrome | Enrichment | LMNA | 1.89 |
| 169 | Thyroid cancer, nonmedullary, 4 | Enrichment | FOXE1 | 1.89 |
| 170 | 8p23.1 microdeletion syndrome | Enrichment | GATA4 | 1.89 |
| 171 | Spermatogenic failure 61 | Enrichment | STAG3 | 1.89 |
| 172 | Ovarian dysgenesis 6 | Enrichment | NUP107 | 1.89 |
| 173 | Spermatogenic failure 32 | Enrichment | SOHLH1 | 1.89 |
| 174 | Extraoral halitosis due to methanethiol oxidase deficiency | Enrichment | SELENBP1 | 1.89 |
| 175 | Ovarian dysgenesis 7 | Enrichment | MRPS22 | 1.89 |
| 176 | Apraxia | Enrichment | SIL1 | 1.89 |
| 177 | Chronic mast cell leukemia | Enrichment | KIT | 1.89 |
| 178 | Premature ovarian failure 14 | Enrichment | GDF9 | 1.89 |
| 179 | Tufted angioma of skin | Enrichment | KDR | 1.89 |
| 180 | Maple syrup urine disease, type ib | Enrichment | BCKDHB | 1.89 |
| 181 | Premature ovarian failure 16 | Enrichment | BNC1 | 1.89 |
| 182 | Premature ovarian failure 9 | Enrichment | HFM1 | 1.89 |
| 183 | Immature teratoma of ovary | Enrichment | BMP15 | 1.89 |
| 184 | Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | Enrichment | CYP7A1 | 1.89 |
| 185 | Aars2-related disorder | Enrichment | AARS2 | 1.89 |
| 186 | B-lymphoblastic leukemia/lymphoma with etv6-runx1 | Enrichment | RECQL4 | 1.89 |
| 187 | Mandibuloacral dysplasia | Enrichment | LMNA | 1.89 |
| 188 | Atrioventricular block | Enrichment | LMNA | 1.89 |
| 189 | Spermatogenic failure 96 | Enrichment | SPATA22 | 1.89 |
| 190 | Mitochondrial dna depletion syndrome, hepatocerebrorenal form | Enrichment | TWNK | 1.89 |
| 191 | Leukoencephalopathy with vanishing white matter 2 | Enrichment | EIF2B2 | 1.89 |
| 192 | Familial hyperprolactinemia | Enrichment | PRLR | 1.89 |
| 193 | Catechol-o-methyltransferase activity, variation in | Enrichment | COMT | 1.89 |
| 194 | X-linked intellectual disability-cerebellar hypoplasia-spondylo-epiphyseal dysplasia syndrome | Enrichment | RPL10 | 1.89 |
| 195 | Tp63-related disorders | Enrichment | TP63 | 1.89 |
| 196 | Premature ovarian failure 24 | Enrichment | SYCP2L | 1.89 |
| 197 | Isolated bone marrow mastocytosis | Enrichment | KIT | 1.89 |
| 198 | Primary pulmonary hypertension | Enrichment | BMPR2 | 1.89 |
| 199 | B-cell non-hodgkin lymphoma | Enrichment | ATM | 1.89 |
| 200 | Smoldering systemic mastocytosis | Enrichment | KIT | 1.89 |
| 201 | Undifferentiated pleomorphic sarcoma | Enrichment | RECQL4 | 1.89 |
| 202 | Skin hemangioma | Enrichment | GJA4 | 1.89 |
| 203 | Pulmonary hypertension | Enrichment | BMPR2 | 1.89 |
| 204 | Xq27.3q28 duplication syndrome | Enrichment | FMR1 | 1.89 |
| 205 | Drug- or toxin-induced pulmonary arterial hypertension | Enrichment | BMPR2 | 1.89 |
| 206 | Childhood myocerebrohepatopathy spectrum | Enrichment | POLG | 1.89 |
| 207 | Mastocytosis | Enrichment | KIT | 1.89 |
| 208 | Non-classic congenital lipoid adrenal hyperplasia due to star deficency | Enrichment | STAR | 1.89 |
| 209 | Partial atrioventricular septal defect with ventricular hypoplasia | Enrichment | GATA4 | 1.89 |
| 210 | Severe congenital neutropenia 3 | Enrichment | HAX1 | 1.89 |
| 211 | Malignant fibrous histiocytoma | Enrichment | RECQL4 | 1.89 |
| 212 | Congenital plasminogen activator inhibitor type 1 deficiency | Enrichment | SERPINE1 | 1.89 |
| 213 | Cutaneous mastocytoma | Enrichment | KIT | 1.89 |
| 214 | Lmna-related cardiocutaneous progeria syndrome | Enrichment | LMNA | 1.89 |
| 215 | Monostotic fibrous dysplasia | Enrichment | GNAS | 1.89 |
| 216 | Pitt-hopkins-like syndrome | Enrichment | CNTNAP2 | 1.89 |
| 217 | Sall4-related disorders | Enrichment | SALL4 | 1.89 |
| 218 | X-linked microcephaly-growth retardation-prognathism-cryptorchidism syndrome | Enrichment | RPL10 | 1.89 |
| 219 | Typical urticaria pigmentosa | Enrichment | KIT | 1.89 |
| 220 | Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome | Enrichment | PTEN | 1.89 |
| 221 | Nodular urticaria pigmentosa | Enrichment | KIT | 1.89 |
| 222 | Autosomal semi-dominant severe lipodystrophic laminopathy | Enrichment | LMNA | 1.89 |
| 223 | Pseudoxanthomatous diffuse cutaneous mastocytosis | Enrichment | KIT | 1.89 |
| 224 | Telangiectasia macularis eruptiva perstans | Enrichment | KIT | 1.89 |
| 225 | Acute mast cell leukemia | Enrichment | KIT | 1.89 |
| 226 | Mazabraud syndrome | Enrichment | GNAS | 1.89 |
| 227 | Spinocerebellar ataxia with epilepsy | Enrichment | POLG | 1.89 |
| 228 | Plaque-form urticaria pigmentosa | Enrichment | KIT | 1.89 |
| 229 | Recessive mitochondrial ataxia syndrome | Enrichment | POLG | 1.89 |
| 230 | Bullous diffuse cutaneous mastocytosis | Enrichment | KIT | 1.89 |
| 231 | Primary peritoneal carcinoma | Enrichment | BRCA1 | 1.89 |
| 232 | Classic congenital lipoid adrenal hyperplasia due to star deficency | Enrichment | STAR | 1.89 |
| 233 | Autosomal recessive axonal hereditary motor and sensory neuropathy | Enrichment | LMNA | 1.89 |
| 234 | Agnosia | Enrichment | SIL1 | 1.89 |
| 235 | Laminopathy | Enrichment | LMNA | 1.89 |
| 236 | Testis seminoma | Enrichment | KIT | 1.89 |
| 237 | Medulloblastoma | Enrichment | BRCA2, WRN | 1.88 |
| 238 | Lipoid congenital adrenal hyperplasia | Enrichment | CYP17A1, STAR | 1.88 |
| 239 | Heart disease | Enrichment | GATA4, RECQL4 | 1.88 |
| 240 | Cataract | Enrichment | SIL1, WRN | 1.88 |
| 241 | Pituitary stalk interruption syndrome | Enrichment | FANCA, FANCG | 1.88 |
| 242 | Wilms tumor 1 | Enrichment | BRCA2, WT1 | 1.82 |
| 243 | Lynch syndrome | Enrichment | FANCM, TGFBR2 | 1.82 |
| 244 | Male infertility with spermatogenesis disorder | Enrichment | FANCM, TP63 | 1.82 |
| 245 | Hypoparathyroidism, familial isolated, 1 | Enrichment | AIRE | 1.60 |
| 246 | Ectrodactyly, ectodermal dysplasia, and cleft lip/palate syndrome 1 | Enrichment | TP63 | 1.60 |
| 247 | Pseudohypoparathyroidism, type ia | Enrichment | GNAS | 1.60 |
| 248 | Precocious puberty, male-limited | Enrichment | LHCGR | 1.60 |
| 249 | Baller-gerold syndrome | Enrichment | RECQL4 | 1.60 |
| 250 | Woodhouse-sakati syndrome | Enrichment | DCAF17 | 1.60 |
| 251 | Leydig cell hypoplasia, type i | Enrichment | LHCGR | 1.60 |
| 252 | Mandibuloacral dysplasia with type a lipodystrophy | Enrichment | LMNA | 1.60 |
| 253 | Denys-drash syndrome | Enrichment | WT1 | 1.60 |
| 254 | Dihydrolipoamide dehydrogenase deficiency | Enrichment | BCKDHB | 1.60 |
| 255 | Optic disc anomalies with retinal and/or macular dystrophy | Enrichment | C14orf39 | 1.60 |
| 256 | Canavan disease | Enrichment | SPATA22 | 1.60 |
| 257 | Hypogonadotropic hypogonadism 24 with or without anosmia | Enrichment | FSHB | 1.60 |
| 258 | Galactosemia i | Enrichment | GALT | 1.60 |
| 259 | Pulmonary venoocclusive disease 1, autosomal dominant | Enrichment | BMPR2 | 1.60 |
| 260 | Spermatogenic failure 4 | Enrichment | HFM1 | 1.60 |
| 261 | Toe syndactyly, telecanthus, and anogenital and renal malformations | Enrichment | STAR | 1.60 |
| 262 | Ovarian germ cell cancer | Enrichment | FANCM | 1.60 |
| 263 | Nephrotic syndrome, type 4 | Enrichment | WT1 | 1.60 |
| 264 | Vacterl association, x-linked, with or without hydrocephalus | Enrichment | FANCL | 1.60 |
| 265 | Rothmund-thomson syndrome, type 2 | Enrichment | RECQL4 | 1.60 |
| 266 | Fanconi anemia, complementation group i | Enrichment | POLG | 1.60 |
| 267 | Loeys-dietz syndrome 2 | Enrichment | TGFBR2 | 1.60 |
| 268 | Pigmented nodular adrenocortical disease, primary, 1 | Enrichment | GNAS | 1.60 |
| 269 | Pseudopseudohypoparathyroidism | Enrichment | GNAS | 1.60 |
| 270 | Premature ovarian failure 3 | Enrichment | FOXL2 | 1.60 |
| 271 | Piebald trait | Enrichment | KIT | 1.60 |
| 272 | Microvascular complications of diabetes 5 | Enrichment | TGFBR2 | 1.60 |
| 273 | Heart-hand syndrome, slovenian type | Enrichment | LMNA | 1.60 |
| 274 | Lymphangioleiomyomatosis | Enrichment | TSC2 | 1.60 |
| 275 | Charcot-marie-tooth disease, axonal, type 2b1 | Enrichment | LMNA | 1.60 |
| 276 | Duane-radial ray syndrome | Enrichment | SALL4 | 1.60 |
| 277 | Ovarian dysgenesis 3 | Enrichment | PSMC3IP | 1.60 |
| 278 | Fibrodysplasia ossificans progressiva | Enrichment | BMPR2 | 1.60 |
| 279 | Frasier syndrome | Enrichment | WT1 | 1.60 |
| 280 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism | Enrichment | LMNA | 1.60 |
| 281 | Orthostatic hypotension 1 | Enrichment | DBH | 1.60 |
| 282 | Myasthenic syndrome, congenital, 22 | Enrichment | PREPL | 1.60 |
| 283 | Lig4 syndrome | Enrichment | XRCC4 | 1.60 |
| 284 | Hydrops, lactic acidosis, and sideroblastic anemia | Enrichment | LARS2 | 1.60 |
| 285 | Sarcoidosis 1 | Enrichment | HLA-DRB1 | 1.60 |
| 286 | Angioma, tufted | Enrichment | KDR | 1.60 |
| 287 | Fatty liver disease 1 | Enrichment | ATG7 | 1.60 |
| 288 | Pitt-hopkins-like syndrome 1 | Enrichment | CNTNAP2 | 1.60 |
| 289 | Heterotaxy, visceral, 4, autosomal | Enrichment | ACVR2B | 1.60 |
| 290 | Leukoencephalopathy, progressive, with ovarian failure | Enrichment | AARS2 | 1.60 |
| 291 | Cardiomyopathy, dilated, 1d | Enrichment | LMNA | 1.60 |
| 292 | Restrictive dermopathy 2 | Enrichment | LMNA | 1.60 |
| 293 | Premature ovarian failure 13 | Enrichment | MSH5 | 1.60 |
| 294 | Emery-dreifuss muscular dystrophy 3, autosomal recessive | Enrichment | LMNA | 1.60 |
| 295 | Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1 | Enrichment | POLG | 1.60 |
| 296 | Fanconi anemia, complementation group s | Enrichment | BRCA1 | 1.60 |
| 297 | Cardiac valvular dysplasia, x-linked | Enrichment | ATM | 1.60 |
| 298 | Leukoencephalopathy with vanishing white matter 4 | Enrichment | EIF2B4 | 1.60 |
| 299 | Werner syndrome | Enrichment | WRN | 1.60 |
| 300 | Oocyte/zygote/embryo maturation arrest 3 | Enrichment | ZP3 | 1.60 |
| 301 | Perrault syndrome 6 | Enrichment | ERAL1 | 1.60 |
| 302 | Pulmonary venoocclusive disease 1 | Enrichment | BMPR2 | 1.60 |
| 303 | Perrault syndrome 3 | Enrichment | CLPP | 1.60 |
| 304 | Pancreatic cancer 4 | Enrichment | BRCA1 | 1.60 |
| 305 | Cornea plana | Enrichment | C14orf39 | 1.60 |
| 306 | Immunodeficiency 127 | Enrichment | TNF | 1.60 |
| 307 | Mitochondrial dna depletion syndrome 11 | Enrichment | MGME1 | 1.60 |
| 308 | Bladder exstrophy | Enrichment | TP63 | 1.60 |
| 309 | Diffuse midline glioma, h3 k27m-mutant | Enrichment | BRCA2 | 1.60 |
| 310 | Spermatogenic failure | Enrichment | SOHLH1 | 1.60 |
| 311 | Spermatogenic failure 74 | Enrichment | MSH5 | 1.60 |
| 312 | Dopamine beta-hydroxylase deficiency | Enrichment | DBH | 1.60 |
| 313 | Lipodystrophy, familial partial, type 1 | Enrichment | LMNA | 1.60 |
| 314 | Spinocerebellar ataxia, autosomal recessive 31 | Enrichment | ATG7 | 1.60 |
| 315 | Pseudohypoparathyroidism | Enrichment | GNAS | 1.60 |
| 316 | Depressive disorder | Enrichment | TWNK | 1.60 |
| 317 | Skraban-deardorff syndrome | Enrichment | WDR62 | 1.60 |
| 318 | Autoimmune thyroid disease 3 | Enrichment | TG | 1.60 |
| 319 | High grade glioma | Enrichment | ATM | 1.60 |
| 320 | Fanconi anemia, complementation group d1 | Enrichment | BRCA2 | 1.60 |
| 321 | Bullous pemphigoid | Enrichment | HLA-DRB1 | 1.60 |
| 322 | Perrault syndrome 4 | Enrichment | LARS2 | 1.60 |
| 323 | T-cell prolymphocytic leukemia | Enrichment | ATM | 1.60 |
| 324 | Proximal symphalangism | Enrichment | NOG | 1.60 |
| 325 | Polg-related disorders | Enrichment | POLG | 1.60 |
| 326 | Spermatogenic failure 22 | Enrichment | MEIOB | 1.60 |
| 327 | Autosomal recessive progressive external ophthalmoplegia | Enrichment | POLG | 1.60 |
| 328 | Hereditary mixed polyposis syndrome | Enrichment | BMPR1A | 1.60 |
| 329 | Fissured tongue | Enrichment | TP63 | 1.60 |
| 330 | Peritoneum cancer | Enrichment | BRCA1 | 1.60 |
| 331 | Leydig cell hypoplasia type ii | Enrichment | LHCGR | 1.60 |
| 332 | Cockayne syndrome type 3 | Enrichment | ERCC6 | 1.60 |
| 333 | Colobomatous optic disc-macular atrophy-chorioretinopathy syndrome | Enrichment | C14orf39 | 1.60 |
| 334 | Galactosemia | Enrichment | GALT | 1.60 |
| 335 | Multifocal pattern dystrophy simulating fundus flavimaculatus | Enrichment | UBR2 | 1.60 |
| 336 | Pediatric multiple sclerosis | Enrichment | HLA-DRB1 | 1.60 |
| 337 | Familial partial lipodystrophy | Enrichment | LMNA | 1.60 |
| 338 | 2p21 microdeletion syndrome without cystinuria | Enrichment | PREPL | 1.60 |
| 339 | Vacterl with hydrocephalus | Enrichment | PTEN | 1.60 |
| 340 | Acth-independent macronodular adrenal hyperplasia | Enrichment | GNAS | 1.60 |
| 341 | Premature ovarian failure 23 | Enrichment | MEIOB | 1.60 |
| 342 | Malignant germ cell tumor of ovary | Enrichment | FANCM | 1.60 |
| 343 | Pulmonary venoocclusive disease | Enrichment | BMPR2 | 1.60 |
| 344 | Malignant granulosa cell tumor of the ovary | Enrichment | FOXL2 | 1.60 |
| 345 | B-lymphoblastic leukemia/lymphoma with t | Enrichment | KIT | 1.60 |
| 346 | Charcot-marie-tooth disease type 2b1 | Enrichment | LMNA | 1.60 |
| 347 | Microcephalic primordial dwarfism-insulin resistance syndrome | Enrichment | XRCC4 | 1.60 |
| 348 | Desmoplastic small round cell tumor | Enrichment | WT1 | 1.60 |
| 349 | Idiopathic/heritable pulmonary arterial hypertension | Enrichment | BMPR2 | 1.60 |
| 350 | Neuroendocrine tumor of pancreas | Enrichment | BRCA2 | 1.60 |
| 351 | Myeloma, multiple | Enrichment | ATM, BRCA2, RECQL4 | 1.46 |
| 352 | Brachydactyly, type a1 | Enrichment | BMPR1B | 1.42 |
| 353 | Mccune-albright syndrome | Enrichment | GNAS | 1.42 |
| 354 | Brachydactyly, type c | Enrichment | BMPR1B | 1.42 |
| 355 | Retinoblastoma | Enrichment | FANCM | 1.42 |
| 356 | Thyroid carcinoma, familial medullary | Enrichment | ESR2 | 1.42 |
| 357 | Mesothelioma, malignant | Enrichment | WT1 | 1.42 |
| 358 | Ataxia-telangiectasia | Enrichment | ATM | 1.42 |
| 359 | Juvenile polyposis syndrome | Enrichment | BMPR1A | 1.42 |
| 360 | Acromesomelic dysplasia 2a | Enrichment | BMPR1B | 1.42 |
| 361 | Acromesomelic dysplasia 2c | Enrichment | BMPR1B | 1.42 |
| 362 | Maple syrup urine disease, type ia | Enrichment | BCKDHB | 1.42 |
| 363 | Nijmegen breakage syndrome | Enrichment | NBN | 1.42 |
| 364 | Acromesomelic dysplasia 2b | Enrichment | BMPR1B | 1.42 |
| 365 | Autoimmune polyendocrine syndrome, type i, with or without reversible metaphyseal dysplasia | Enrichment | AIRE | 1.42 |
| 366 | Adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency | Enrichment | CYP17A1 | 1.42 |
| 367 | D-bifunctional protein deficiency | Enrichment | HSD17B4 | 1.42 |
| 368 | Polycythemia vera | Enrichment | ATM | 1.42 |
| 369 | Tuberous sclerosis 1 | Enrichment | TSC2 | 1.42 |
| 370 | Leukoencephalopathy, hereditary diffuse, with spheroids 1 | Enrichment | AARS2 | 1.42 |
| 371 | Mullerian duct aplasia, unilateral renal agenesis, and cervicothoracic somite anomalies | Enrichment | WNT4 | 1.42 |
| 372 | De sanctis-cacchione syndrome | Enrichment | ERCC6 | 1.42 |
| 373 | Polycystic kidney disease, infantile severe, with tuberous sclerosis | Enrichment | TSC2 | 1.42 |
| 374 | 46,xx sex reversal 1 | Enrichment | NR5A1 | 1.42 |
| 375 | Intellectual developmental disorder, x-linked 109 | Enrichment | AFF2 | 1.42 |
| 376 | Restrictive dermopathy 1 | Enrichment | LMNA | 1.42 |
| 377 | Multicentric osteolysis, nodulosis, and arthropathy | Enrichment | MMP2 | 1.42 |
| 378 | Uv-sensitive syndrome 1 | Enrichment | ERCC6 | 1.42 |
| 379 | Mitochondrial dna depletion syndrome 7 | Enrichment | TWNK | 1.42 |
| 380 | Body mass index quantitative trait locus 12 | Enrichment | PCSK1 | 1.42 |
| 381 | Psoriatic arthritis | Enrichment | TNF | 1.42 |
| 382 | Aromatase excess syndrome | Enrichment | CYP19A1 | 1.42 |
| 383 | Hypotonia-cystinuria syndrome | Enrichment | PREPL | 1.42 |
| 384 | Estrogen resistance | Enrichment | ESR1 | 1.42 |
| 385 | Lipodystrophy, familial partial, type 2 | Enrichment | LMNA | 1.42 |
| 386 | Tuberous sclerosis 2 | Enrichment | TSC2 | 1.42 |
| 387 | Infantile cerebellar-retinal degeneration | Enrichment | POLR3H | 1.42 |
| 388 | Optic atrophy 9 | Enrichment | POLR3H | 1.42 |
| 389 | Muscular dystrophy, congenital, lmna-related | Enrichment | LMNA | 1.42 |
| 390 | Tumor predisposition syndrome 1 | Enrichment | BRCA2 | 1.42 |
| 391 | Proprotein convertase 1/3 deficiency | Enrichment | PCSK1 | 1.42 |
| 392 | Koolen-de vries syndrome | Enrichment | ATM | 1.42 |
| 393 | Uv-sensitive syndrome | Enrichment | ERCC6 | 1.42 |
| 394 | Premature ovarian failure 11 | Enrichment | ERCC6 | 1.42 |
| 395 | Chronic progressive external ophthalmoplegia | Enrichment | TWNK | 1.42 |
| 396 | Loeys-dietz syndrome 1 | Enrichment | TGFBR2 | 1.42 |
| 397 | Hamartoma | Enrichment | TSC2 | 1.42 |
| 398 | Testicular germ cell cancer | Enrichment | KIT | 1.42 |
| 399 | Xanthinuria, type ii | Enrichment | TSC2 | 1.42 |
| 400 | Adenocarcinoma | Enrichment | ATM | 1.42 |
| 401 | Duane retraction syndrome | Enrichment | SALL4 | 1.42 |
| 402 | Gonadal dysgenesis | Enrichment | FSHR | 1.42 |
| 403 | Aromatase deficiency | Enrichment | CYP19A1 | 1.42 |
| 404 | Immunodeficiency, common variable, 11 | Enrichment | IL21 | 1.42 |
| 405 | Laryngeal squamous cell carcinoma | Enrichment | PTEN | 1.42 |
| 406 | Bap1 tumor predisposition syndrome | Enrichment | BRCA2 | 1.42 |
| 407 | Restrictive dermopathy | Enrichment | LMNA | 1.42 |
| 408 | Cushing syndrome due to bilateral macronodular adrenocortical disease | Enrichment | GNAS | 1.42 |
| 409 | Idiopathic camptocormia | Enrichment | POLG | 1.42 |
| 410 | Autoimmune polyendocrine syndrome type 1 | Enrichment | AIRE | 1.42 |
| 411 | Sclerocornea | Enrichment | C14orf39 | 1.42 |
| 412 | Atypical hypotonia-cystinuria syndrome | Enrichment | PREPL | 1.42 |
| 413 | Familial papillary or follicular thyroid carcinoma | Enrichment | FOXE1 | 1.42 |
| 414 | Pulmonary arterial hypertension associated with congenital heart disease | Enrichment | BMPR2 | 1.42 |
| 415 | Keratoacanthoma | Enrichment | NOTCH2 | 1.42 |
| 416 | Vogt-koyanagi-harada disease | Enrichment | HLA-DRB1 | 1.42 |
| 417 | Intermittent maple syrup urine disease | Enrichment | BCKDHB | 1.42 |
| 418 | Classic maple syrup urine disease | Enrichment | BCKDHB | 1.42 |
| 419 | Congenital cornea plana | Enrichment | C14orf39 | 1.42 |
| 420 | Tetralogy of fallot | Enrichment | GATA4, KDR | 1.37 |
| 421 | Kaposi sarcoma | Enrichment | IL6 | 1.30 |
| 422 | Mirror movements 1 | Enrichment | RAD51 | 1.30 |
| 423 | Aniridia 1 | Enrichment | WT1 | 1.30 |
| 424 | Brachydactyly, type a2 | Enrichment | BMPR1B | 1.30 |
| 425 | Hutchinson-gilford progeria syndrome | Enrichment | LMNA | 1.30 |
| 426 | Mulibrey nanism | Enrichment | TRIM37 | 1.30 |
| 427 | Cystinuria | Enrichment | PREPL | 1.30 |
| 428 | Chordoma | Enrichment | BRCA2 | 1.30 |
| 429 | Temporal arteritis | Enrichment | HLA-DRB1 | 1.30 |
| 430 | Emery-dreifuss muscular dystrophy 1, x-linked | Enrichment | LMNA | 1.30 |
| 431 | Pseudohypoparathyroidism, type ib | Enrichment | GNAS | 1.30 |
| 432 | Microtia-anotia | Enrichment | LMNA | 1.30 |
| 433 | Fragile x tremor/ataxia syndrome | Enrichment | FMR1 | 1.30 |
| 434 | Focal cortical dysplasia, type ii | Enrichment | TSC2 | 1.30 |
| 435 | Macular degeneration, age-related, 5 | Enrichment | ERCC6 | 1.30 |
| 436 | Oocyte/zygote/embryo maturation arrest 1 | Enrichment | ZP3 | 1.30 |
| 437 | Spermatogenic failure 1 | Enrichment | NR5A1 | 1.30 |
| 438 | Mantle cell lymphoma | Enrichment | ATM | 1.30 |
| 439 | Arthrogryposis multiplex congenita 3, myogenic type | Enrichment | ESR1 | 1.30 |
| 440 | Blepharophimosis | Enrichment | FOXL2 | 1.30 |
| 441 | Multiple synostoses syndrome | Enrichment | NOG | 1.30 |
| 442 | Fragile x-associated tremor/ataxia syndrome | Enrichment | FMR1 | 1.30 |
| 443 | Emery-dreifuss muscular dystrophy | Enrichment | LMNA | 1.30 |
| 444 | Generalized epilepsy | Enrichment | POLG | 1.30 |
| 445 | Tuberous sclerosis | Enrichment | TSC2 | 1.30 |
| 446 | Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) | Enrichment | KIT | 1.30 |
| 447 | 2p21 microdeletion syndrome | Enrichment | PREPL | 1.30 |
| 448 | Intermediate maple syrup urine disease | Enrichment | BCKDHB | 1.30 |
| 449 | Sick sinus syndrome | Enrichment | LMNA | 1.30 |
| 450 | Cerebral malaria | Enrichment | TNF | 1.30 |
| 451 | Vacterl association | Enrichment | FANCL | 1.30 |
| 452 | Systemic mastocytosis with associated hematologic neoplasm | Enrichment | KIT | 1.30 |
| 453 | Transposition of the great arteries | Enrichment | GATA4 | 1.30 |
| 454 | Isolated focal cortical dysplasia type ii | Enrichment | TSC2 | 1.30 |
| 455 | Glioma | Enrichment | PTEN | 1.30 |
| 456 | Cleft lip and alveolus | Enrichment | TP63 | 1.30 |
| 457 | Oculomotor apraxia | Enrichment | ATM | 1.30 |
| 458 | Pseudomyogenic hemangioendothelioma | Enrichment | SERPINE1 | 1.30 |
| 459 | Cockayne syndrome a | Enrichment | ERCC6 | 1.21 |
| 460 | Vater/vacterl association | Enrichment | FANCL | 1.21 |
| 461 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative | Enrichment | SALL4 | 1.21 |
| 462 | Fragile x syndrome | Enrichment | FMR1 | 1.21 |
| 463 | Rhabdomyosarcoma 2 | Enrichment | FOXO1 | 1.21 |
| 464 | Macrocephaly/autism syndrome | Enrichment | PTEN | 1.21 |
| 465 | Rheumatoid arthritis, systemic juvenile | Enrichment | IL6 | 1.21 |
| 466 | Leber congenital amaurosis 10 | Enrichment | WT1 | 1.21 |
| 467 | Narcolepsy 2 | Enrichment | HLA-DRB1 | 1.21 |
| 468 | Mitochondrial complex iii deficiency, nuclear type 4 | Enrichment | COX10 | 1.21 |
| 469 | Pontocerebellar hypoplasia, type 2d | Enrichment | PCCA | 1.21 |
| 470 | Ventricular septal defect 1 | Enrichment | GATA4 | 1.21 |
| 471 | Congenital heart defects, multiple types, 4 | Enrichment | GATA4 | 1.21 |
| 472 | Follicular lymphoma | Enrichment | HLA-DRB1 | 1.21 |
| 473 | Autosomal recessive limb-girdle muscular dystrophy type 2b | Enrichment | LMNA | 1.21 |
| 474 | Acute myeloid leukemia with maturation | Enrichment | KIT | 1.21 |
| 475 | Glioblastoma | Enrichment | ATM | 1.21 |
| 476 | Pseudohermaphroditism | Enrichment | LHCGR | 1.21 |
| 477 | Hemangioma | Enrichment | PTEN | 1.21 |
| 478 | Histiocytoid hemangioma | Enrichment | LMNA | 1.21 |
| 479 | Nonsyndromic 46,xx testicular disorders/differences of sex development | Enrichment | NR5A1 | 1.21 |
| 480 | Vascular dementia | Enrichment | TNF | 1.21 |
| 481 | Acute megakaryocytic leukemia | Enrichment | PTEN | 1.21 |
| 482 | Cleft upper lip | Enrichment | TP63 | 1.21 |
| 483 | Hemimegalencephaly | Enrichment | PTEN | 1.21 |
| 484 | Familial glucocorticoid deficiency | Enrichment | STAR | 1.21 |
| 485 | Acute myeloid leukemia with t(8;21)(q22;q22) translocation | Enrichment | KIT | 1.21 |
| 486 | Generalized juvenile polyposis/juvenile polyposis coli | Enrichment | BMPR1A | 1.21 |
| 487 | Familial cerebral saccular aneurysm | Enrichment | TGFBR3 | 1.21 |
| 488 | Lung cancer | Enrichment | BRCA1, ERCC6 | 1.20 |
| 489 | Genetic steroid-resistant nephrotic syndrome | Enrichment | NUP107, WT1 | 1.16 |
| 490 | Cockayne syndrome b | Enrichment | ERCC6 | 1.13 |
| 491 | Kabuki syndrome 1 | Enrichment | BRCA2 | 1.13 |
| 492 | Emery-dreifuss muscular dystrophy 2, autosomal dominant | Enrichment | LMNA | 1.13 |
| 493 | Machado-joseph disease | Enrichment | POLG | 1.13 |
| 494 | Cowden syndrome 1 | Enrichment | PTEN | 1.13 |
| 495 | Adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency | Enrichment | CYP17A1 | 1.13 |
| 496 | Cerebrooculofacioskeletal syndrome 1 | Enrichment | ERCC6 | 1.13 |
| 497 | Type 1 diabetes mellitus | Enrichment | IL6 | 1.13 |
| 498 | Testicular germ cell tumor | Enrichment | KIT | 1.13 |
| 499 | Wilms tumor 5 | Enrichment | WT1 | 1.13 |
| 500 | Mitochondrial dna depletion syndrome 1 | Enrichment | POLG | 1.13 |
| 501 | Mitochondrial dna depletion syndrome | Enrichment | POLG | 1.13 |
| 502 | Familial thyroid dyshormonogenesis | Enrichment | TG | 1.13 |
| 503 | Clear cell renal cell carcinoma | Enrichment | ATM | 1.13 |
| 504 | Breast adenocarcinoma | Enrichment | AKT1 | 1.13 |
| 505 | 46,xy disorder of sex development | Enrichment | NR5A1 | 1.13 |
| 506 | 21-hydroxylase-deficient congenital adrenal hyperplasia | Enrichment | CYP17A1 | 1.13 |
| 507 | Esophageal cancer | Enrichment | TGFBR2 | 1.07 |
| 508 | Bethlem myopathy 1a | Enrichment | LMNA | 1.07 |
| 509 | Polycystic kidney disease 1 with or without polycystic liver disease | Enrichment | TSC2 | 1.07 |
| 510 | Thyroid cancer, nonmedullary, 2 | Enrichment | PTEN | 1.07 |
| 511 | Mitochondrial dna depletion syndrome 4a | Enrichment | POLG | 1.07 |
| 512 | Hypothyroidism, congenital, nongoitrous, 2 | Enrichment | FOXE1 | 1.07 |
| 513 | Squamous cell carcinoma, head and neck | Enrichment | PTEN | 1.07 |
| 514 | Coats disease | Enrichment | RCBTB1 | 1.07 |
| 515 | Gastrointestinal stromal tumor | Enrichment | KIT | 1.07 |
| 516 | Renal cell carcinoma, papillary, 1 | Enrichment | ATM | 1.07 |
| 517 | Brachydactyly | Enrichment | GNAS | 1.07 |
| 518 | Third-degree atrioventricular block | Enrichment | TWNK | 1.07 |
| 519 | Neutropenia | Enrichment | HAX1 | 1.07 |
| 520 | Polycystic kidney disease 1 | Enrichment | TSC2 | 1.07 |
| 521 | Cockayne syndrome | Enrichment | ERCC6 | 1.07 |
| 522 | Follicular thyroid carcinoma | Enrichment | PTEN | 1.07 |
| 523 | Systemic lupus erythematosus | Enrichment | HLA-DRB1, TNF | 1.05 |
| 524 | Narcolepsy 1 | Enrichment | HLA-DRB1 | 1.01 |
| 525 | Spastic paraplegia 4, autosomal dominant | Enrichment | GNAS | 1.01 |
| 526 | Mitochondrial dna depletion syndrome 4b | Enrichment | POLG | 1.01 |
| 527 | Exudative vitreoretinopathy | Enrichment | RCBTB1 | 1.01 |
| 528 | Severe congenital neutropenia | Enrichment | HAX1 | 1.01 |
| 529 | Cryptorchidism | Enrichment | INSL3 | 1.01 |
| 530 | Congenital muscular dystrophy | Enrichment | LMNA | 1.01 |
| 531 | Hypothyroidism | Enrichment | TG | 1.01 |
| 532 | Myocarditis | Enrichment | LMNA | 1.01 |
| 533 | Isolated split hand-split foot malformation | Enrichment | TP63 | 1.01 |
| 534 | Mitochondrial disease | Enrichment | AARS2, POLG, TWNK | 1.00 |
| 535 | Type 2 diabetes mellitus | Enrichment | IL6, WRN | 1.00 |
| 536 | Tooth agenesis, selective, 1 | Enrichment | BMPR2 | 0.96 |
| 537 | Tracheoesophageal fistula with or without esophageal atresia | Enrichment | BRCA2 | 0.96 |
| 538 | Cryptorchidism, unilateral or bilateral | Enrichment | INSL3 | 0.96 |
| 539 | Inflammatory bowel disease 1 | Enrichment | IL6 | 0.96 |
| 540 | Polydactyly | Enrichment | BRCA2 | 0.96 |
| 541 | Arrhythmogenic right ventricular dysplasia, familial, 9 | Enrichment | LMNA | 0.96 |
| 542 | Leukemia, acute lymphoblastic 3 | Enrichment | WT1 | 0.96 |
| 543 | Loeys-dietz syndrome | Enrichment | TGFBR2 | 0.96 |
| 544 | Adult hepatocellular carcinoma | Enrichment | TSC2 | 0.96 |
| 545 | Congenital central hypoventilation syndrome | Enrichment | BDNF | 0.96 |
| 546 | Primary hyperaldosteronism | Enrichment | GNAS | 0.96 |
| 547 | Colonic benign neoplasm | Enrichment | ATM | 0.96 |
| 548 | Autosomal dominant cerebellar ataxia | Enrichment | POLG | 0.96 |
| 549 | Mitochondrial neurogastrointestinal encephalomyopathy | Enrichment | POLG | 0.96 |
| 550 | Lynch syndrome 1 | Enrichment | ATM | 0.92 |
| 551 | Marfan syndrome | Enrichment | TGFBR2 | 0.92 |
| 552 | Leukemia, chronic lymphocytic | Enrichment | ATM | 0.92 |
| 553 | Aplastic anemia | Enrichment | NBN | 0.92 |
| 554 | Galloway-mowat syndrome | Enrichment | NUP107 | 0.92 |
| 555 | Neurodegeneration with brain iron accumulation | Enrichment | DCAF17 | 0.92 |
| 556 | Melanoma | Enrichment | PTEN | 0.92 |
| 557 | Isolated tracheo-esophageal fistula | Enrichment | BRCA2 | 0.92 |
| 558 | Migraine with or without aura 1 | Enrichment | ESR1 | 0.88 |
| 559 | Immune deficiency disease | Enrichment | ATM | 0.88 |
| 560 | Asthma | Enrichment | TNF | 0.88 |
| 561 | Meningioma, familial | Enrichment | PTEN | 0.88 |
| 562 | Leukemia, acute lymphoblastic | Enrichment | NBN | 0.88 |
| 563 | Mitochondrial myopathy | Enrichment | LARS2 | 0.88 |
| 564 | Cardiac conduction defect | Enrichment | LMNA | 0.85 |
| 565 | Muscular dystrophy, limb-girdle, autosomal recessive 2 | Enrichment | LMNA | 0.85 |
| 566 | Digeorge syndrome | Enrichment | COMT | 0.85 |
| 567 | Congenital hypothyroidism | Enrichment | TG | 0.85 |
| 568 | Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variant | Enrichment | LMNA | 0.85 |
| 569 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-left variant | Enrichment | LMNA | 0.85 |
| 570 | Lip and oral cavity carcinoma | Enrichment | KIT | 0.85 |
| 571 | Pulmonary hypertension, primary, 1 | Enrichment | BMPR2 | 0.81 |
| 572 | Alzheimer's disease | Enrichment | TNF | 0.81 |
| 573 | Oligospermia | Enrichment | MSH4 | 0.81 |
| 574 | Autism spectrum disorder | Enrichment | CNTNAP2, PTEN, TSC2 | 0.79 |
| 575 | Multiple sclerosis | Enrichment | HLA-DRB1 | 0.78 |
| 576 | Aortic aneurysm, familial thoracic 1 | Enrichment | GATA4 | 0.78 |
| 577 | Periventricular nodular heterotopia | Enrichment | BRCA1 | 0.78 |
| 578 | Cox deficiency, benign infantile mitochondrial myopathy | Enrichment | COX10 | 0.78 |
| 579 | Cleft lip/palate | Enrichment | TP63 | 0.78 |
| 580 | Inherited isolated arrhythmogenic cardiomyopathy, dominant-right variant | Enrichment | LMNA | 0.78 |
| 581 | Renal cell carcinoma, nonpapillary | Enrichment | ATM | 0.76 |
| 582 | Autosomal dominant polycystic kidney disease | Enrichment | TSC2 | 0.76 |
| 583 | Kidney disease | Enrichment | WT1 | 0.76 |
| 584 | Arrhythmogenic right ventricular cardiomyopathy | Enrichment | LMNA | 0.73 |
| 585 | Gliosarcoma | Enrichment | ATM | 0.73 |
| 586 | Cardiomyopathy, dilated, 1e | Enrichment | LMNA | 0.71 |
| 587 | Cataract 44 | Enrichment | PGRMC1 | 0.71 |
| 588 | Syndromic intellectual disability | Enrichment | PTH2R | 0.71 |
| 589 | Giant cell glioblastoma | Enrichment | ATM | 0.71 |
| 590 | Heart, malformation of | Enrichment | GATA4 | 0.69 |
| 591 | Human immunodeficiency virus type 1 | Enrichment | CXCL12 | 0.69 |
| 592 | Neuromuscular disease | Enrichment | LMNA | 0.69 |
| 593 | Patent foramen ovale | Enrichment | GATA4 | 0.69 |
| 594 | Arteriovenous malformations of the brain | Enrichment | IL6 | 0.66 |
| 595 | Neuropathy, hereditary motor and sensory, okinawa type | Enrichment | LMNA | 0.66 |
| 596 | Esophageal atresia/tracheoesophageal fistula | Enrichment | BRCA2 | 0.66 |
| 597 | Ehlers-danlos syndrome | Enrichment | TGFBR2 | 0.66 |
| 598 | Focal segmental glomerulosclerosis | Enrichment | WT1 | 0.64 |
| 599 | Autism | Enrichment | CNTNAP2, SPATA22 | 0.63 |
| 600 | Cardiomyopathy, dilated, 1a | Enrichment | LMNA | 0.63 |
| 601 | Lissencephaly | Enrichment | NBN | 0.63 |
| 602 | Hepatocellular carcinoma | Enrichment | NBN | 0.61 |
| 603 | Mitochondrial complex iv deficiency, nuclear type 1 | Enrichment | COX10 | 0.61 |
| 604 | Myocardial infarction | Enrichment | ESR1 | 0.61 |
| 605 | Visceral heterotaxy | Enrichment | ACVR2B | 0.61 |
| 606 | Microphthalmia | Enrichment | C14orf39 | 0.61 |
| 607 | Brittle bone disorder | Enrichment | EIF2B2 | 0.59 |
| 608 | Malaria | Enrichment | TNF | 0.59 |
| 609 | Cardiomyopathy, familial hypertrophic, 1 | Enrichment | LMNA | 0.58 |
| 610 | Familial atrial fibrillation | Enrichment | GATA4 | 0.58 |
| 611 | Muscular dystrophy | Enrichment | LMNA | 0.58 |
| 612 | Rare genetic deafness | Enrichment | HSD17B4, LARS2 | 0.57 |
| 613 | Brugada syndrome | Enrichment | LMNA | 0.55 |
| 614 | Strabismus | Enrichment | SIL1 | 0.53 |
| 615 | Severe covid-19 | Enrichment | RECQL4 | 0.51 |
| 616 | Differentiated thyroid carcinoma | Enrichment | FOXE1 | 0.51 |
| 617 | Long qt syndrome | Enrichment | LMNA | 0.48 |
| 618 | Primary autosomal recessive microcephaly | Enrichment | WDR62 | 0.47 |
| 619 | Connective tissue disease | Enrichment | TGFBR2 | 0.47 |
| 620 | Peripheral nervous system disease | Enrichment | LMNA | 0.47 |
| 621 | Neuropathy | Enrichment | LMNA | 0.47 |
| 622 | Male infertility | Enrichment | NR5A1 | 0.45 |
| 623 | Left ventricular noncompaction | Enrichment | LMNA | 0.44 |
| 624 | Non-syndromic x-linked intellectual disability | Enrichment | AGTR2 | 0.43 |
| 625 | Non-syndromic genetic deafness | Enrichment | LARS2 | 0.43 |
| 626 | Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes | Enrichment | POLG | 0.41 |
| 627 | Cerebral palsy | Enrichment | BRCA2 | 0.40 |
| 628 | Leukemia, acute myeloid | Enrichment | KIT | 0.40 |
| 629 | Charcot-marie-tooth disease | Enrichment | LMNA | 0.39 |
| 630 | Benign epilepsy with centrotemporal spikes | Enrichment | CNTNAP2 | 0.39 |
| 631 | Bardet-biedl syndrome | Enrichment | COMT | 0.38 |
| 632 | Hereditary spastic paraplegia | Enrichment | POLG | 0.38 |
| 633 | Nonsyndromic hearing loss | Enrichment | LARS2 | 0.38 |
| 634 | Centralopathic epilepsy | Enrichment | CNTNAP2 | 0.37 |
| 635 | Hypertrophic cardiomyopathy | Enrichment | POLG | 0.37 |
| 636 | Optic atrophy plus syndrome | Enrichment | POLR3H | 0.36 |
| 637 | West syndrome | Enrichment | TSC2 | 0.36 |
| 638 | Familial thoracic aortic aneurysm and aortic dissection | Enrichment | TGFBR2 | 0.36 |
| 639 | Sensorineural hearing loss | Enrichment | HARS2 | 0.34 |
| 640 | Familial isolated dilated cardiomyopathy | Enrichment | LMNA | 0.31 |
| 641 | Schizophrenia | Enrichment | COMT | 0.27 |
| 642 | Leigh syndrome, nuclear | Enrichment | POLG | 0.23 |
| 643 | Dilated cardiomyopathy | Enrichment | LMNA | 0.19 |
| 644 | Microcephaly | Enrichment | NBN | 0.10 |
| 645 | Hereditary retinal dystrophy | Enrichment | RCBTB1, UBR2 | 0.05 |
| 646 | Fundus dystrophy | Enrichment | RCBTB1, UBR2 | 0.05 |
| 647 | Retinitis pigmentosa | Enrichment | RCBTB1 | 0.03 |